Literature DB >> 10367897

CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation.

A Avots1, M Buttmann, S Chuvpilo, C Escher, U Smola, A J Bannister, U R Rapp, T Kouzarides, E Serfling.   

Abstract

NF-ATc, an inducibly expressed transcription factor, controls gene expression in T lymphocytes and cardiomyocytes. We show here that the transcriptional co-activators CBP/p300 bind to and control the activity of the inducible N-terminal transactivation domain of NF-ATc, TAD-A. Similar to the N terminal transactivation domain of c-Jun, TAD-A is inducibly phosphorylated, but this phosphorylation is dispensable for the interaction with CBP/p300. Constitutive active versions of c-Raf and Rac synergistically enhance the CBP/p300-mediated increase of TAD-A activity, indicating the important role CBP/p300 plays in the integration of T cell activation signals. Since a mutation of CBP abolishing HAT activity is almost as active as wild-type CBP in T cells, functions of CBP/p300 other than histone acetylation appear to control the NF-AT-dependent transcription in T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367897     DOI: 10.1016/s1074-7613(00)80051-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  27 in total

1.  Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells.

Authors:  Whitney S Helms; Jerry L Jeffrey; Derek A Holmes; Michael B Townsend; Neil A Clipstone; Lishan Su
Journal:  J Leukoc Biol       Date:  2007-05-14       Impact factor: 4.962

Review 2.  Regulation of T cell differentiation and function by epigenetic modification enzymes.

Authors:  Huicheng Liu; Pingfei Li; Zhengping Wei; Cai Zhang; Minghui Xia; Qiuyang Du; Yufei Chen; Na Liu; Huabin Li; Xiang-Ping Yang
Journal:  Semin Immunopathol       Date:  2019-04-08       Impact factor: 9.623

3.  Inducible gene deletion reveals different roles for B-Raf and Raf-1 in B-cell antigen receptor signalling.

Authors:  Tilman Brummer; Peter E Shaw; Michael Reth; Yukiko Misawa
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

4.  Nfatc2 is a primary response gene of Nell-1 regulating chondrogenesis in ATDC5 cells.

Authors:  Weiwei Chen; Xinli Zhang; Ronald K Siu; Feng Chen; Jia Shen; Janette N Zara; Cymbeline T Culiat; Sotirios Tetradis; Kang Ting; Chia Soo
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

Review 5.  Function and regulation of class II transactivator in the immune system.

Authors:  Cheong-Hee Chang; Tania S Gourley; Tyler J Sisk
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

6.  Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases.

Authors:  Teddy T C Yang; Qiufang Xiong; Hervé Enslen; Roger J Davis; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

7.  A modular enhancer is differentially regulated by GATA and NFAT elements that direct different tissue-specific patterns of nucleosome positioning and inducible chromatin remodeling.

Authors:  Andrew G Bert; Brett V Johnson; Euan W Baxter; Peter N Cockerill
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

8.  Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization.

Authors:  Brett V Johnson; Andrew G Bert; Gregory R Ryan; Antony Condina; Peter N Cockerill
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells.

Authors:  Chia-Cheng Wu; Shu-Ching Hsu; Hsiu-Ming Shih; Ming-Zong Lai
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 10.  Control of IL-4 expression in T helper 1 and 2 cells.

Authors:  Jane Gilmour; Paul Lavender
Journal:  Immunology       Date:  2008-05-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.